Testing the safety of an experimental drug in healthy adults
Part of Brain & nervous system clinical trials.
This is an early study to test a new drug called LY03017 in healthy adults. It will check how safe the drug is and how your body handles it at different dose levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are in good overall health
- You weigh at least 110 lbs (50 kg) if male, or 99 lbs (45 kg) if female, with a healthy BMI
- You are not taking certain medications or supplements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study looks at how a new investigational drug (LY03017) moves through the body when taken with or without food, and how it works in younger adults (18–45) compared to older adults (65+). Participation could help researchers find the right dose and understand how the drug is processed, which is a first step toward finding a treatment.
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
Hear when a new Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.